A database of FDA approved therapeutic peptides and proteins
ID1608 | ThPPIDTh1131 | NameTaliglucerase Alfa | Peptide SequenceEFARPCIPKSFGYSSVVCVC Full view | Length504 | Functional ClassificationIa | DiseaseHormonal | BrandElelyso | CompanyPfizer | Physical AppearanceSterile, non-pyrogenic, lyophilized product. | Route of AdministartionIntravenous infusion | CategoryEnzymes | TargetGlucocerebroside |
ID1624 | ThPPIDTh1137 | NameTeduglutide | Peptide SequenceHGDGSFSDEMNTILDNLAAR Full view | Length33 | Functional ClassificationIa | DiseaseMalabsorption disorder | BrandGattex | CompanyNPS Pharmaceuticals, Inc | Physical AppearanceClear, colorless to light-straw–colored liquid. | Route of AdministartionSubcutaneous injection | CategoryN.A. | TargetGlucagon-like peptide 2 receptor |
ID1634 | ThPPIDTh1140 | NameInsulin, Isophane Or Nph Insulin (Neutral Protamine Hagedorn) | Peptide SequenceA chain: GIVEQCCTSIC Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic | BrandNovolin N | CompanyNovo Nordisk | Physical AppearanceNovolin N InnoLet (nph, human insulin isophane suspension 3 ml disposable prefilled syringe) | Route of AdministartionSubcutaneous injection | CategoryHypoglycemic Agents and Antidiabetic Agents | TargetInsulin receptor |
ID1666 | ThPPIDTh1157 | NameSermorelin | Peptide SequenceYADAIFTNSYRKVLGQLSAR Full view | Length30 | Functional ClassificationIa | DiseaseHormonal | BrandSermorelin acetate | CompanyEmd serono inc | Physical AppearanceSterile, non-pyrogenic, lyophilized powder | Route of AdministartionSubcutaneous Injection | CategoryHormone Replacement Agents | TargetGrowth hormone-releasing hormone receptor |
ID1684 | ThPPIDTh1164 | NameAntithrombin Alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandAtryn | CompanyGtc Biotherapeutics, Inc. | Physical AppearanceInjection, Powder, Lyophilized, for Solution | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1685 | ThPPIDTh1164 | NameAntithrombin Alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandAtryn | CompanyR Evo Bioloigics, Inc. | Physical AppearanceInjection, Powder, Lyophilized, for Solution | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1687 | ThPPIDTh1165 | NameAntithrombin III human | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandThrombate III | CompanyGRIFOLS USA, LLC | Physical Appearancekit | Route of AdministartionNA | CategoryNA | TargetNA |
ID1688 | ThPPIDTh1165 | NameAntithrombin III human | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandThrombate III | CompanyGrifols Therapeutics Inc | Physical AppearancePowder for Solution | Route of AdministartionNA | CategoryNA | TargetNA |
ID1691 | ThPPIDTh1165 | NameAntithrombin III human | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandThrombate III Pws IV 1000iu/vial | CompanyMiles Inc. Pharmaceutical Division | Physical AppearancePowder for Solution | Route of AdministartionNA | CategoryNA | TargetNA |
ID1694 | ThPPIDTh1166 | NameAsfotase Alfa | Peptide SequenceLVPEKEKDPKYWRDQAQETL Full view | Length726 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandStrensiq | CompanyAlexion Pharma Ghbh | Physical AppearanceSolution | Route of AdministartionSubcutaneous | CategoryEnzymes Alimentary Tract and Metabolism | TargetSphingosine 1-phosphate receptor 1; Pyrophosphate |
ID1695 | ThPPIDTh1166 | NameAsfotase Alfa | Peptide SequenceLVPEKEKDPKYWRDQAQETL Full view | Length726 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandStrensiq | CompanyAlexion Pharmaceuticals Inc. | Physical AppearanceSolution | Route of AdministartionSubcutaneous | CategoryEnzymes Alimentary Tract and Metabolism | TargetSphingosine 1-phosphate receptor 1; Pyrophosphate |
ID1704 | ThPPIDTh1168 | NameAutologous cultured chondrocytes | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseOsteological Disorders | BrandCarticel | CompanyGenzyme Corporation | Physical AppearanceImplant | Route of AdministartionIntra-auricular | CategoryNA | TargetNA |
ID1706 | ThPPIDTh1169 | NameBeractant | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseRespiratory | BrandSurvanta | CompanyAbb Vie Inc. | Physical AppearanceSuspension | Route of AdministartionEndotracheal | CategoryNA | TargetNA |
ID1707 | ThPPIDTh1169 | NameBeractant | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseRespiratory Disorder | BrandSurvanta | CompanyAbbvie Corporation | Physical AppearanceSuspension | Route of AdministartionIntratracheal | CategoryNA | TargetNA |
ID1715 | ThPPIDTh1171 | NameC1 Esterase Inhibitor (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandBerinert 1500 | CompanyCsl Behring Canada Inc | Physical Appearancekit; Powder for Solution | Route of AdministartionIntravenous | CategoryNA | TargetPlasma protease C1 inhibitor |
ID1717 | ThPPIDTh1171 | NameC1 Esterase Inhibitor (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandCinryze | CompanyViropharma Biologics Inc | Physical AppearancePowder for Solution | Route of AdministartionIntravenous | CategoryNA | TargetPlasma protease C1 inhibitor |
ID1719 | ThPPIDTh1172 | NameCoagulation Factor XIII A-Subunit (Recombinant) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandTretten | CompanyNovo Nordisk | Physical AppearanceKit | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1720 | ThPPIDTh1172 | NameCoagulation Factor XIII A-Subunit (Recombinant) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandTretten | CompanyNovo Nordisk Canada Inc | Physical AppearancePowder for Solution | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1722 | ThPPIDTh1173 | NameConestat alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandRuconest | CompanyPharming; Santarus, Inc. | Physical AppearancePowder for Solution | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1736 | ThPPIDTh1177 | NameElosulfase alfa | Peptide SequenceAPQPPNILLLLMDDMGWGDL Full view | Length496 | Functional ClassificationIa | DiseaseMetabolic Disorders | BrandVimizim | CompanyBiomarin International Limited | Physical AppearanceSolution | Route of AdministartionIntravenous | CategoryEnzymes; Alimentary Tract and Metabolism | TargetN-acetylgalactosamine-6-sulfatase |
ID1745 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandRiastap | CompanyCsl Behring Gmb H | Physical AppearanceInjection, Powder, Lyophilized, for Solution | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1746 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandArtiss Frozen | CompanyBaxter Healthcare Corporation | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1747 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandEvicel Fibrin Sealant (human) | CompanyEthicon Inc | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1748 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandRaplixa | CompanyPro Fibrix Bv | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1749 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandTachosil | CompanyBaxter Healthcare Corporation | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1750 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandTisseel | CompanyBaxter Healthcare Corporation | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1751 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandTisseel Frozen | CompanyBaxter Healthcare Corporation | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1799 | ThPPIDTh1193 | NameTuroctocog alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandZonovate | CompanyNovo Nordisk Canada Inc | Physical Appearancesterile, non-pyrogenic, white or slightly yellow Powder | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1801 | ThPPIDTh1195 | NameSimoctocog Alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandNuwiq | CompanyOctapharma Pharmazeutika Produktionsges M B H | Physical AppearancePowder and solvent for Solution | Route of AdministartionIntravenous infusion | CategoryAntihaemorrhagics: blood coagulation factor VIII | TargetNA |
ID1803 | ThPPIDTh1197 | NameSebelipase alfa | Peptide SequenceSGGKLTAVDPETNMNVSEII Full view | Length378 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandKanuma | CompanyAlexion Pharmaceuticals, Inc. | Physical AppearanceAqueous Solution | Route of AdministartionIntravenous infusion | CategoryEnzymes | TargetNA |
ID1804 | ThPPIDTh1198 | NameSacrosidase | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandSucraid | CompanyQOL Medical, LLC | Physical AppearanceSolution | Route of AdministartionOral | CategoryEnzymes | TargetNA |
ID1806 | ThPPIDTh1200 | NameProthrombin complex concentrate | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandFeiba Nf | CompanyBaxter Healthcare Corporation | Physical AppearanceFreeze-dried fraction | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1807 | ThPPIDTh1200 | NameProthrombin complex concentrate | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandCofact | CompanySanquin | Physical AppearanceNA | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1808 | ThPPIDTh1200 | NameProthrombin complex concentrate | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandKcentra | CompanyCsl Behring Ag | Physical AppearanceNanofiltered and Lyophilized non-activated four-factor Prothrombin Complex Concentrate | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1809 | ThPPIDTh1200 | NameProthrombin complex concentrate | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandOctaplex | CompanyOctapharma | Physical AppearancePowder and solvent for Solution | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1810 | ThPPIDTh1201 | NamePoractant alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseRespiratory Disorder | BrandCurosurf | CompanyChiesi USA, Inc | Physical AppearanceSuspension | Route of AdministartionEndotracheal | CategoryPulmonary Surfactants | Target |
ID1812 | ThPPIDTh1203 | NamePeginterferon beta-1a | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseNeurological Disorder | BrandPlegridy | CompanyBiogen Canada Inc | Physical AppearanceSterile Solution | Route of AdministartionSubcutaneous | CategoryNA | Target |
ID1821 | ThPPIDTh1212 | NameInsulin Pork | Peptide SequenceA chain GIVEQCCTSICS Full view | Length68 | Functional ClassificationIa | DiseaseMetabolic Disorders | BrandIletin II | CompanyLilly | Physical Appearancesterile suspension | Route of AdministartionSubcutaneous | CategoryHypoglycemic Agents, Antidiabetic Agents | TargetInsulin receptor, Insulin-like growth factor 1 receptor, Insulin-degrading enzyme, HLA class II histocompatibility antigen, DQ alpha 2 chain, HLA class II histocompatibility antigen, DQ beta 1 chain, Retinoblastoma-associated protein, Cathepsin D, Carboxypeptidase E, Neuroendocrine convertase 2, Neuroendocrine convertase 1, Protein NOV homolog, Low-density lipoprotein receptor-related protein 2, Insulin-like growth factor-binding protein 7, Synaptotagmin-like protein 4, Cytochrome P450 1A2 |
ID1822 | ThPPIDTh1213 | NameInsulin Degludec | Peptide SequenceInsulin degludec dif Full view | Length0 | Functional ClassificationIa | DiseaseMetabolic Disorders | BrandTresiba | CompanyNovo Nordisk | Physical Appearancesterile, aqueous, clear, and colorless Solution | Route of AdministartionSubcutaneous | CategoryNA | TargetNA |
ID1823 | ThPPIDTh1214 | NameInsulin Beef | Peptide SequenceA chain: GIVEQCCASVC Full view | Length71 | Functional ClassificationIa | DiseaseMetabolic Disorders | BrandNA | CompanyNA | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1827 | ThPPIDTh1217 | NameAnti-inhibitor coagulant complex | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandFeiba Nf | CompanyNA | Physical Appearance Solid | Route of AdministartionIntravenous | CategoryBlood Coagulation Factors, Antihemophilic Agent | TargetNA |
ID1833 | ThPPIDTh1223 | NameChorionic Gonadotropin (Human) | Peptide SequenceAlpha Chain: APDVQDC Full view | Length237 | Functional ClassificationIa | DiseaseHormonal Disorders | BrandOvidrel | CompanyEmd Serono | Physical AppearanceInjection, solution | Route of AdministartionSubcutaneous | CategoryHormones | TargetLutropin-choriogonadotropic hormone receptor |
ID1834 | ThPPIDTh1223 | NameChorionic Gonadotropin (Human) | Peptide SequenceAlpha Chain: APDVQDC Full view | Length237 | Functional ClassificationIa | DiseaseHormonal Disorders | BrandPregnyl | CompanyPhysicians Total Care, Inc. | Physical AppearanceInjection, Solution | Route of AdministartionIntramuscular, Subcutaneous | CategoryHormones | TargetLutropin-choriogonadotropic hormone receptor |
ID1835 | ThPPIDTh1224 | NameChorionic Gonadotropin (Recombinant) | Peptide SequenceAlpha chain : APDVQD Full view | Length237 | Functional ClassificationIa | DiseaseHormonal Disorders | BrandOvitrelle | CompanyMerck Serono Europe Limited | Physical Appearancepowder and solvent to be made up into a solution | Route of AdministartionSubcutaneous | CategoryHormones | TargetLutropin-choriogonadotropic hormone receptor, Follicle-stimulating hormone receptor |